FIELD: virology, immunology, veterinary science. SUBSTANCE: vaccine has strain of simian rotavirus SA-11 and platinum (II) derivative with DNA polyanion at concentration (5.3-81) x 10-3 (as measured for platinum). EFFECT: high immunogenicity of vaccine, safety and stability. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF HUMAN CULTURE ROTAVIRUS INACTIVATION | 2019 |
|
RU2738404C1 |
| Method of human culture rotavirus inactivation | 2020 |
|
RU2743300C1 |
| METHOD OF SYNCHRONIZATION OF CELLS AT G1-PHASE OF MITOSIS | 1995 |
|
RU2088661C1 |
| METHOD OF AN ANTIROTAVIRAL IMMUNOGLOBULIN PREPARING | 1998 |
|
RU2129017C1 |
| SORBED INACTIVATED VACCINE AGAINST CATTLE ROTAVIRAL INFECTION | 2005 |
|
RU2302258C1 |
| STRAIN OF HUMAN RHOTAVIRUS FOR PREPARING OF DIAGNOSTIC AND PROPHYLAXIS SERA | 1991 |
|
RU2026345C1 |
| CATTLE ROTAVIRUS STRAIN FOR PRODUCTION OF DIAGNOSIS, VACCINE AND THERAPEUTIC PREPARATIONS | 2004 |
|
RU2264458C1 |
| MIXED VACCINE AGAINST ROTA-, CORONAVIRAL AND ESCHERICHIA DIARRHEA IN NEWBORN PIGLETS | 1998 |
|
RU2137499C1 |
| INACTIVATED COMBINED VACCINE AGAINST VIRAL DIARRHEA, ROTA-, CORONA-VIRUS DISEASES AND ESCHERICHIOSIS OF CATTLE | 2009 |
|
RU2403063C1 |
| COMBINED EMULSION INACTIVATED VACCINE AGAINST ROTAVIRAL AND CORONAVIRAL CATTLE INFECTIONS | 2008 |
|
RU2366458C1 |
